Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
about
Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromesAntioxidants and other pharmacological treatments for Friedreich ataxiaIdebenone for the treatment of Duchenne muscular dystrophyIdebenone for the treatment of Duchenne muscular dystrophyAntioxidants and other pharmacological treatments for Friedreich ataxiaIdebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and TreatmentImpaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxiaCoenzyme Q10 and Neurological Diseases.Prevalence of ataxia in children: a systematic reviewCommon data elements for clinical research in Friedreich's ataxia.Deferiprone targets aconitase: implication for Friedreich's ataxia treatmentLimitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screenAltered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology.Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency.Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation.Neuroferritinopathy: a new inborn error of iron metabolismTherapeutic approaches to spinal and bulbar muscular atrophyCombined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.Past, present and future therapeutics for cerebellar ataxias.Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study.Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblastsFriedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.Longitudinal tracking of gait and balance impairments in cerebellar diseaseMitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich's ataxia.The neuro-ophthalmology of mitochondrial diseaseExercise capacity and idebenone intervention in children and adolescents with Friedreich ataxiaPharmacological treatments for Friedreich ataxia.Co-enzyme Q10 and idebenone use in Friedreich's ataxia.Clinical experience with high-dose idebenone in Friedreich ataxia.Consensus clinical management guidelines for Friedreich ataxia.Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.Consensus paper: management of degenerative cerebellar disorders.Treatment of Leber hereditary optic neuropathyMitochondrial energetics and therapeutics.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Stable isotopes and LC-MS for monitoring metabolic disturbances in Friedreich's ataxia platelets.Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia.
P2860
Q24193064-31BDEC0C-3FFF-4499-B002-A2F257865167Q24200235-07E4ED03-9AC7-42C1-B5C9-A2D230B92FD6Q24201942-0E3FC2F7-DA6F-4525-AA40-B194A7CB25B7Q24236662-946F984E-C16C-47B6-8350-1264DD65A233Q24240370-223A0E28-83BE-4A22-AACA-D9CF9A16128DQ26853254-B0C92757-3C28-4350-9FF6-501A1B986B46Q28078384-2CFBA0D2-7E96-48D5-B42D-A1C299B211D8Q28474531-33A2ED16-4C82-4EBA-BAFA-EC818F6F7EF5Q30440307-C6AFA685-DED5-4B5B-B033-73E01BC0FDC2Q30560727-82A03FFF-1263-4A80-819A-10B73ADDA5CAQ30581588-AC4E3577-C4FB-4456-9E63-F6BD57350EE0Q33344109-CFA87E21-A009-4B17-AFC1-9F11B24187B4Q33496330-CB460CC9-A2E3-4371-A02F-06715E58321FQ33525513-474110C5-CE6A-4388-8DF9-DBC609D851EEQ33527398-0A462A83-1DA1-402D-9B70-D79C31BD9589Q33555894-3D353661-6A9A-4EF6-8989-F7CD42A48CFDQ33685685-21920DA4-27D5-49B4-91A3-8283C7C0E7E8Q33701169-42A00690-DD28-44EC-A16B-E2F97EDACB04Q33701891-1F6F7AFE-08C2-4B9D-B048-AD0970BF44C7Q33836935-E8D9724D-6FD7-4219-AAF7-64334F82EF49Q33968480-EC03B261-9348-484B-BCF1-BEA5BD1D78B0Q34053510-B16C4E2F-3C28-4DB3-92B0-2FC75D64FB05Q34076650-C9CBFECE-22DD-485A-8B7E-4413AC763771Q34126414-2E7E1EDF-4F15-48CD-8B44-55E8B1999007Q34152110-4BB067CA-1AFD-4FB5-BA8D-0857B57DDBA0Q34197370-87D74EA3-9DB4-47E5-957E-BD43BCA0892EQ34317949-A18140D1-07D2-435A-9F42-98C8557CA737Q34338783-F8D0A6DB-612B-48E0-AF2D-A2958F71CD60Q34373154-2EA8B8E4-5824-493C-8FED-B40FD9C09B3FQ34538823-C6B36DBA-BF40-4C59-92DC-18908EAA3401Q34654338-06273AF4-013C-41DE-B509-9687DE862C1AQ34778763-BA248135-C7E5-4786-8E19-03882333E902Q34789144-08B70C1B-C6D6-4F07-9C2D-A1A996CA702AQ35045060-92574EB0-ACF5-4984-A55F-2BEED5F77A48Q35129909-FDE0E12C-94D3-4526-9E56-6915B7AF1509Q35452117-B5CC3225-2D9C-40AE-9582-6A4EAA870E15Q35632864-0DC25699-122E-4A01-AD56-167F8C00A9EAQ35958359-4D5395A3-97F1-4FD4-8C51-6F8178F940D1Q36207736-4F55C79D-28FA-42D6-BBEB-6E2D03927153Q36488119-711C0E4C-F46B-4F01-8C7B-A10549B90477
P2860
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Neurological effects of high-d ...... sed, placebo-controlled trial.
@ast
Neurological effects of high-d ...... sed, placebo-controlled trial.
@en
Neurological effects of high-d ...... sed, placebo-controlled trial.
@nl
type
label
Neurological effects of high-d ...... sed, placebo-controlled trial.
@ast
Neurological effects of high-d ...... sed, placebo-controlled trial.
@en
Neurological effects of high-d ...... sed, placebo-controlled trial.
@nl
prefLabel
Neurological effects of high-d ...... sed, placebo-controlled trial.
@ast
Neurological effects of high-d ...... sed, placebo-controlled trial.
@en
Neurological effects of high-d ...... sed, placebo-controlled trial.
@nl
P2093
P1433
P1476
Neurological effects of high-d ...... sed, placebo-controlled trial.
@en
P2093
Angela Baker
Kenneth H Fischbeck
Neal Jeffries
Nicholas A Di Prospero
P304
P356
10.1016/S1474-4422(07)70220-X
P577
2007-10-01T00:00:00Z